The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Pulmonary Alveolar Proteinosis: Progress in the First 44 Years
Abstract
Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958. Subsequently, over 240 case reports and small series have described at least 410 cases in the literature. Characterized by the alveolar accumulation of surfactant components with minimal interstitial inflammation or fibrosis, pulmonary alveolar proteinosis has a variable clinical course ranging from spontaneous resolution to death with pneumonia or respiratory failure. The most effective proven treatment--whole lung lavage--was described soon after the first recognition of this disease. In the last 8 years, there has been rapid progress toward elucidation of the molecular mechanisms underlying both the congenital and acquired forms of pulmonary alveolar proteinosis, following serendipitous discoveries in gene-targeted mice lacking granulocyte-macrophage colony-stimulating factor (GM-CSF). Impairment of surfactant clearance by alveolar macrophages as a result of inhibition of the action of GM-CSF by blocking autoantibodies may underlie many acquired cases, whereas congenital disease is most commonly attributable to mutations in surfactant protein genes but may also be caused by GM-CSF receptor defects. Therapy with GM-CSF has shown promise in approximately half of those acquired cases treated, but it is unsuccessful in congenital forms of the disease, consistent with the known differences in disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
THE GROWTH OF MOUSE BONE MARROW CELLS IN VITRO
Bradley, T., & Metcalf, D. (1966) · Australian Journal of Experimental Biology and Medical Science · doi:10.1038/icb.1966.28 · Cited by 1,926
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Pulmonary Alveolar Proteinosis
Rosen, S. H., Castleman, B., Liebow, A. A., Enzinger, F. M., & Hunt, R. T. N. (1958) · New England Journal of Medicine · doi:10.1056/nejm195806052582301 · Cited by 1,150
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Macrophages and Polymorphonuclear Neutrophils in Lung Defense and Injury
Sibille, Y., & Reynolds, H. Y. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.471 · Cited by 1,083
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
A Mutation in the Surfactant Protein C Gene Associated with Familial Interstitial Lung Disease
Nogee, L. M., Dunbar, A. E., Wert, S. E., Askin, F., Hamvas, A., & Whitsett, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440805 · Cited by 929
Stanley, E., Lieschke, G. J., Grail, D., Metcalf, D., Hodgson, G., Gall, J. A., Maher, D. W., Cebon, J., Sinickas, V, & Dunn, A. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5592 · Cited by 882
Cited by
Pulmonary Alveolar Proteinosis
Trapnell, B. C., Whitsett, J. A., & Nakata, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023226 · Cited by 790
Inoue, Y., Trapnell, B. C., Tazawa, R., Arai, T., Takada, T., Hizawa, N., Kasahara, Y., Tatsumi, K., Hojo, M., Ichiwata, T., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1271oc · Cited by 490
Alveolar Surfactant Homeostasis and the Pathogenesis of Pulmonary Disease
Whitsett, J. A., Wert, S. E., & Weaver, T. E. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123500 · Cited by 487
Silica‐related diseases in the modern world
Hoy, R. F., & Chambers, D. C. (2020) · Allergy · doi:10.1111/all.14202 · Cited by 415
Pulmonary alveolar proteinosis
Trapnell, B. C., Nakata, K., Bonella, F., Campo, I., Griese, M., Hamilton, J., Wang, T., Morgan, C., Cottin, V., & McCarthy, C. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0066-3 · Cited by 397
Schneider, C., Nobs, S. P., Heer, A. K., Kurrer, M., Klinke, G., van Rooijen, N., Vogel, J., & Kopf, M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004053 · Cited by 334
Vinh, D. C., Patel, S. Y., Uzel, G., Anderson, V. L., Freeman, A. F., Olivier, K. N., Spalding, C., Hughes, S., Pittaluga, S., Raffeld, M., et al. (2010) · Blood · doi:10.1182/blood-2009-03-208629 · Cited by 330
Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases
King, T. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-483oe · Cited by 330
GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis
Uchida, K., Beck, D. C., Yamamoto, T., Berclaz, P.-Y., Abe, S., Staudt, M. K., Carey, B. C., Filippi, M.-D., Wert, S. E., Denson, L. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062505 · Cited by 317
Pulmonary macrophage transplantation therapy
Suzuki, T., Arumugam, P., Sakagami, T., Lachmann, N., Chalk, C., Sallese, A., Abe, S., Trapnell, C., Carey, B., Moritz, T., et al. (2014) · Nature · doi:10.1038/nature13807 · Cited by 307
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA
Suzuki, T., Sakagami, T., Rubin, B. K., Nogee, L. M., Wood, R. E., Zimmerman, S. L., Smolarek, T., Dishop, M. K., Wert, S. E., Whitsett, J. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080990 · Cited by 305
Pulmonary alveolar proteinosis
Borie, R., Danel, C., Debray, M.-P., Taille, C., Dombret, M.-C., Aubier, M., Epaud, R., & Crestani, B. (2011) · European Respiratory Review · doi:10.1183/09059180.00001311 · Cited by 301
Diseases of Pulmonary Surfactant Homeostasis
Whitsett, J. A., Wert, S. E., & Weaver, T. E. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104644 · Cited by 256
Sinclair, C., Bommakanti, G., Gardinassi, L., Loebbermann, J., Johnson, M. J., Hakimpour, P., Hagan, T., Benitez, L., Todor, A., Machiah, D., et al. (2017) · Science · doi:10.1126/science.aaj2155 · Cited by 126
Distinct Responses of Human Monocyte Subsets to Aspergillus fumigatus Conidia
Serbina, N. V., Cherny, M., Shi, C., Bleau, S. A., Collins, N. H., Young, J. W., & Pamer, E. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803398 · Cited by 70
Souza, C. A., Marchiori, E., Gonçalves, L. P., Meirelles, G. D. S. P., Zanetti, G., Escuissato, D. L., Capobianco, J., & Souza, A. S. (2012) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.12.012 · Cited by 30
Metadata
- Authors
- Seymour, J. F., & Presneill, J. J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-07-15
- Volume
- 166
- Issue
- 2
- Pages
- 215-235
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2108046487
- Cited by
- 697
- References
- 182
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.